logo
Scientists Discover a Simple Set of Rules That May Explain How Our Tissues Stay Organized

Scientists Discover a Simple Set of Rules That May Explain How Our Tissues Stay Organized

Business Wire15-07-2025
WILMINGTON, Del.--(BUSINESS WIRE)--Every day, your body replaces billions of cells—and yet, your tissues stay perfectly organized. How is that possible?
'Just like we have a genetic code that explains how our genes work, we may also have a 'tissue code' that explains how our bodies stay so precisely organized over time,' said Bruce Boman, M.D., Ph.D.
Share
A team of researchers at ChristianaCare's Helen F. Graham Cancer Center & Research Institute and the University of Delaware believe they've found an answer. In a new study published today in the scientific journal Biology of the Cell, they show that just five basic rules may explain how the body maintains the complex structure of tissues like those in the colon, for example, even as its cells are constantly dying and being replaced.
Download photos.
This research is the product of more than 15 years of collaboration between mathematicians and cancer biologists to unlock the rules that govern tissue structure and cellular behavior.
'This may be the biological version of a blueprint,' said Bruce Boman, M.D., Ph.D., senior research scientist at ChristianaCare's Cawley Center for Translational Cancer Research and faculty member in the departments of Biological Sciences and Mathematical Sciences at the University of Delaware. 'Just like we have a genetic code that explains how our genes work, we may also have a 'tissue code' that explains how our bodies stay so precisely organized over time.'
Math Meets Medicine
The researchers used mathematical modeling—essentially, creating a computer simulation of how cells behave—to see if a small number of rules could account for the highly organized structure of the lining of the colon. That's an ideal place to study: cells in the colon renew every few days, but the overall shape and structure stays remarkably stable.
After running many simulations and refining their models, the team identified five core biological rules that appear to govern the structure and behavior of cells:
Timing of cell division.
The order in which cells divide.
The direction cells divide and move.
How many times cells divide.
How long a cell lives before it dies.
'These rules work together like choreography,' said Gilberto Schleiniger, Ph.D., professor in the University of Delaware's Department of Mathematical Sciences. 'They control where cells go, when they divide and how long they stick around—and that's what keeps tissues looking and working the way they should.'
Decoding Human Tissue
The researchers believe these rules may apply not just to the colon, but to many different tissues throughout the body—skin, liver, brain and beyond. If true, this 'tissue code' could help scientists better understand how tissues heal after injury, how birth defects happen and how diseases like cancer develop when that code gets disrupted.
Boman explained it this way: 'Your tissues don't just grow and shrink randomly. They know what they're supposed to look like, and they know how to get back to that state, even after damage. That level of precision needs a set of instructions. What we've found is a strong candidate for those instructions.'
This work also has important implications for the Human Cell Atlas, a global scientific collaboration working to map every cell type in the human body. While the Atlas aims to catalog what each cell is and what it's doing at a given moment, this new research offers a dynamic framework for understanding how those cells stay organized over time. By identifying simple, universal rules that govern cell behavior and tissue structure, the findings could help guide future efforts to not only describe cells, but predict how they behave in health and disease.
Implications for Disease and Discovery
One reason the team turned to mathematical models, rather than traditional biology experiments, is that it's extremely difficult to observe how every single cell in a tissue behaves in real time. But with computer models, researchers can run simulations that reveal patterns and dynamics hidden from view.
This kind of collaboration between biology and math reflects a broader shift in how scientists approach complex problems. It also aligns with national priorities: the National Science Foundation's ' Rules of Life ' initiative challenges researchers to uncover the fundamental principles that govern living systems. This study is a strong step in that direction.
Next steps for the team include testing the model's predictions experimentally, refining it with additional data and exploring its relevance to cancer biology—especially how disruptions to the tissue code may lead to tumor growth or metastasis.
'This is just the beginning,' said Schleiniger. 'Once you can identify the rules, you can begin to ask entirely new questions, and maybe even learn how to fix what's gone wrong.'
Funding for this project was provided by the National Institutes of Health, the National Science Foundation, The Lisa Dean Moseley Foundation, the Delaware Bioscience Center for Advanced Technology (CAT) and the UNIDEL Graduate Research Fellowship.
About ChristianaCare
Headquartered in Wilmington, Delaware, ChristianaCare is one of the country's most dynamic health care organizations, centered on improving health outcomes, and innovating to make high-quality care more accessible, equitable and affordable. ChristianaCare includes an extensive network of primary care and outpatient services, home health care, urgent care centers, three hospitals (1,430 beds), a freestanding emergency department, a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women's health. It also includes the pioneering Gene Editing Institute.
ChristianaCare is nationally recognized as a great place to work, rated by Forbes as one of the nation's best employers for diversity and inclusion. ChristianaCare is rated by Newsweek as one of the World's Best Hospitals and is continually ranked among the best in the U.S. in national quality and safety ratings. ChristianaCare is a nonprofit teaching health system with more than 260 residents and fellows. With its groundbreaking Center for Virtual Health and a focus on population health and value-based care, ChristianaCare is shaping the future of health care.
About the Cawley Center for Translational Cancer Research
The Cawley Center for Translational Cancer Research (CTCR) at the Helen F. Graham Cancer Center & Research Institute moves research from the laboratory bench to the patient's bedside by applying basic science toward potential therapies. The Cawley CTCR is where scientists study the molecular causes of cancer and tissue engineering, all targeted to better treatment for patients. Groundbreaking findings and current studies at the center are helping to prevent, better detect and stop the growth of many cancers — and as a result reducing cancer incidence and mortality rates in Delaware and beyond.
About the University of Delaware
The University of Delaware traces its roots to 1743, making it the seventh-oldest higher education institution in the country. UD's tradition of excellence continues today in both the classroom and the laboratory, with consistent ranking among the top 40 public universities. Beyond its Georgian-inspired main campus in Newark, Delaware, UD has locations in Wilmington, Dover, Georgetown and Lewes, in addition to a growing online learning environment.
UD is a state-assisted, privately governed institution and one of a select group to hold the triple Land Grant, Sea Grant and Space Grant designation. UD is classified nationally as a Research 1 (R1) university for its very high research activity and doctorate production, a designation held by less than 5% of U.S. colleges and universities. UD also is recognized as a Community Engaged University for its long tradition of applying knowledge and creativity to the critical challenges facing communities in Delaware and around the world.
About the University of Delaware's Department of Mathematical Sciences
The University of Delaware's Department of Mathematical Sciences offers a diverse suite of programs – from actuarial science and applied mathematics to mathematics‑and‑economics, mathematics education, and quantitative biology – designed to develop both deep theoretical insight and practical problem-solving skills. The department's vibrant community of scholars and educators is anchored by the Mathematical Sciences Learning Lab and the Center for Applications of Mathematics in Medicine. Faculty and students collaborate on cutting‑edge research across pure and applied mathematics – exploring topics such as algebra, topology, probability, and graph theory – and join forces with colleagues in computer science, data science, engineering, biology, and neuroscience.
About the University of Delaware's Department of Biological Sciences
The Department of Biological Sciences at the University of Delaware is a dynamic and interdisciplinary community of scholars, researchers, and educators. With a proud legacy of academic excellence and a strong track record of external research funding, the department offers an exceptional undergraduate experience that blends classroom instruction, problem-based learning, hands-on lab training, and mentored research in faculty labs. This comprehensive approach equips students with the skills and knowledge to thrive in a wide range of careers or advanced studies. At the graduate level, the department focuses on uncovering the molecular mechanisms of life, using bacterial, invertebrate, and vertebrate model systems to advance understanding and improve human health and society. Our collaborative teaching and research environment spans molecular biology and genetics, developmental biology, cell and tissue physiology, microbiology, and science education – creating a vibrant, inclusive, and impactful scientific community.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Rising Cost of Living Is Becoming a Mental Health Crisis for Young Employees
The Rising Cost of Living Is Becoming a Mental Health Crisis for Young Employees

Yahoo

time26 minutes ago

  • Yahoo

The Rising Cost of Living Is Becoming a Mental Health Crisis for Young Employees

Modern Health's new workplace report finds 75% blame financial stress for fueling burnout and hurting productivity, 79% sacrifice mental health to meet work demands and 96% want preventative mental health support SAN FRANCISCO, July 23, 2025--(BUSINESS WIRE)--A new report from Modern Health, a global premium mental health solution provider, reveals a troubling picture of how Gen Z and Millennial employees are faring: only 16% rate their current mental health as excellent, with the vast majority grappling with anxiety fueled by economic uncertainty and financial stress that is taxing work productivity and personal time. In a survey of 1,000 American professionals aged 18 to 44, 79% not only feel anxious from economic uncertainty, concerningly they are also sacrificing their mental health to meet work demands. "Our latest report reveals that many of today's young workers are quietly pushing through mounting mental health challenges just to keep up at work," said Matt Levin, CEO of Modern Health. "They're not getting the support they need, which should be a wake-up call for employers. We can't afford to wait until someone is in crisis to act—we need to meet people earlier, with care that's proactive, adaptive, and designed to support the mental health of entire workforce populations." Anxiety is the New Cost of Living Financial anxiety and economic uncertainty are a key driver of mental health challenges for today's employees. Three in four say financial stress is fueling their burnout and hurting their productivity, 76% say financial anxiety is disrupting their sleep, mood and energy and directly impacting their productivity at work, and 68% say financial anxiety regularly interferes with their ability to do their jobs effectively. Financial and economic concerns are also dissuading employees from taking positive professional and personal actions in their lives. A resounding 74% of employees say they've delayed taking time off work due to financial concerns, while more than half (55%) have postponed seeking mental health care for the same reason. Even more concerning, 69% say they're staying in toxic job environments or avoiding necessary career changes due to economic fears. Repercussions of Hustle Culture The report reveals a troubling level of skepticism among younger employees when it comes to their employers' commitment to mental health. A striking 71% believe their employer uses mental health initiatives to mask a toxic culture, while 61% describe their company culture as flawed. Over half (53%) say their employer encourages self-care but makes it nearly impossible to practice. This erosion of trust is potentially fueling an unhealthy pace of work and worsening mental health in the workplace. A high majority (79%) say they routinely sacrifice their mental health to keep up with work demands, and 77% admit to checking emails during PTO, or avoiding time off altogether for fear of falling behind. Even when employees do take time off, 68% report feeling guilty, worrying it will be viewed as unproductive, or admit feeling pressure to "power through." Just 21% of employees say they can truly unplug without pressure from work. Alarmingly, 77% say they've worked through a mental health crisis because they felt they couldn't take a break. "The disconnect employees feel between their mental health needs and the realities of the workplace is a signal—not of failure, but of opportunity," said Dr. Jessica Watrous, Senior Director of Clinical Research & Scientific Affairs at Modern Health. "Many employers are doing their best to support well-being, but employees are still feeling pressure to be 'always on,' even when it impacts their health. By creating cultures that enable people to truly unplug and ask for help without guilt, organizations can build the kind of trust and resilience that helps both people and businesses thrive—especially in today's unpredictable environment." The Mental Health Care Gap and the High Cost of Inaction One of the most urgent challenges in workplace mental health today is the gap between when employees need support and when they actually receive it. The desire for early access to resources—before one is in crisis—is widespread, with a staggering 96% wanting access to preventative mental health support as a workplace benefit and 94% stating that they believe it would make a positive difference in their work lives. Spotlighting the growing care gap, 58% of employees admit they've waited until symptoms became unmanageable before getting help. The incentive for employers to close this gap is clear. Employees overwhelmingly believe access to preventative support would make a meaningful difference: 52% say they would feel more positive about their company, 51% say it would boost their productivity, and 49% believe it would help them avoid burnout altogether. And it's not just employees—99% of Gen Z and Millennial managers agree that workforce mental health programs positively impact overall business goals with almost half (49%) stating they directly influence business performance and results. For companies that fail to meet these needs, the stakes are high. More than half (52%) of respondents say they've considered quitting their job to protect their mental health—a clear signal that action is no longer optional. Worryingly, 1 in 7 young workers are actively searching for a new job for this very reason. "It's not surprising to hear that younger employees want mental health support before they're in crisis—it's something we see every day," said Alison Borland, Modern Health's Chief People and Strategy Officer. "For many, caring for their mental health is part of how they stay balanced and show up at work and in life—and they expect their employer to support that. Mental health can't just be treated as a problem to fix after it escalates. It needs to be a strategic priority, which means offering proactive, personalized support that evolves with people's needs. At Modern Health, we call this adaptive care—and it's not only the right thing to do for employees, it's a proven way to retain top talent and reduce healthcare costs." To learn more, download the full report here. About Modern Health Modern Health is a global leader in adaptive mental health care, dynamically offering multi-modal mental health support that delivers meaningful outcomes at a sustainable, predictable cost. With therapy, psychiatry, coaching, community groups, self-guided tools, and crisis support we dynamically create individualized care journeys to address a spectrum of mental health needs and preferences with culturally responsive providers in 200+ countries and territories and 80+ languages. Backed by peer-reviewed research and a proprietary blend of technology and live support, Modern Health delivers measurable outcomes, globally equitable access, and sustainable pricing. Our industry-leading Adaptive Care Model and dedicated, human centered, operationally tuned, customer success partners make us a trusted partner for organizations worldwide. Visit us at to learn how we can help you optimize your people and your business. Methodology Modern Health commissioned this scientific random sample of 1,000 U.S. adults (aged 18-44). This group was surveyed between June 5, 2025 and June 6, 2025. All respondents are currently employed for wages, confirmed by consumer-matched data. Sampling was calibrated to obtain a representative demographic sample aligned with U.S. workforce statistics. DKC Analytics conducted and analyzed this survey with a sample procured using the Pollfish survey delivery platform, which delivers online surveys globally through mobile apps and the mobile web along with the desktop web. No post-stratification has been applied to the results. View source version on Contacts press@

GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100

Yahoo

time39 minutes ago

  • Yahoo

GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100

Increased R&D investments to integrate AI on devices across disease states designed to boost productivity, efficiency, and diagnostic confidence for healthcare professionals, and drive the company's long-term growth Milestone advances GE HealthCare's goal of attaining more than 200 authorizations by 2028 CHICAGO, July 23, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S. This milestone reflects GE HealthCare's continued research and development (R&D) investment and focus on developing AI solutions to advance precision care by enhancing medical devices across the care journey. Smart devices, software, and cloud-based solutions, which are central to GE HealthCare's precision care strategy, help enhance outcomes for patients, improve the daily work of care teams, and boost healthcare professional efficiency. These AI-enabled devices help solve customer challenges and are in high demand, which contributes to orders, revenue, and growth for the company. The momentum demonstrates GE HealthCare's progress toward achieving its goal of securing more than 200 authorizations. "Our sustained leadership in AI-enabled medical devices reflects our commitment to research and development, which is powering the creation of next-generation solutions. These solutions are designed to address the toughest challenges our customers are facing including care team shortages and burnout, rising costs, and inefficient workflows," said Dr. Taha Kass-Hout, GE HealthCare's Global Chief Science and Technology Officer. "As we continue to drive the industry forward, we remain committed to doing so in a responsible way, building in our Responsible AI principles at every stage of our product development which include a focus on safety, validity, transparency, explainability, and fairness." The FDA's webpage, Artificial Intelligence-Enabled Medical Devices, provides a list of device authorizations, granted through 510(k) clearances, De Novo requests, or by premarket approval (PMA). GE HealthCare's 100 authorizations to date demonstrate innovation across imaging modalities and care pathways including oncology, cardiology, and neurology, helping to ease the burden of care and improve workflows for healthcare systems. Examples of GE HealthCare's AI solutions that are helping solve customer challenges and driving growth include: AI-based Auto Positioning uses deep learning to automatically detect anatomical landmarks, which are used to determine the patient's orientation inside computed tomography (CT) and positron emission tomography (PET)/CT devices, including Revolution Apex platform and Omni Legend. The solution helps minimize the action required by technologists into a single click operation, enabling faster patient positioning compared to traditional manual positioning operations.1 AIR™ Recon DL is a pioneering deep learning algorithm for image reconstruction that enables radiologists to achieve pin-sharp images quicker. By combining magnetic resonance imaging (MRI) with deep learning, AIR™ Recon DL reduces artifacts, enhances image clarity, and shortens scan times by up to 50%.2 It has been estimated that more than 50 million patients have been scanned since its launch in 2020.3 The LOGIQ™ Series ultrasound portfolio of systems empowers clinicians to scan, diagnose, and treat a wide range of patients and conditions. With AI-powered automation, real-time workflow enhancements, and exceptional image quality, the LOGIQ Series is designed to facilitate faster, more efficient scanning and support diagnostic precision. Intelligent anatomy recognition enables dynamic image optimization as well as repeatable and reproducible automated measurements and results – providing elevated accuracy and greater diagnostic confidence. Precision DL is deep learning-based image processing, available on the Omni Legend PET/CT system, that enhances image quality in PET/CT scans, providing clinicians with a powerful solution to aid in precise diagnoses, treatment planning, and monitoring with the image quality performance benefits typically associated with hardware-based Time-of-Flight (ToF) reconstruction, without compromising sensitivity, including improved contrast-to-noise ratio, contrast recovery4, and quantitative accuracy.5 Venue Family point-of-care ultrasound systems with AI-powered Caption Guidance™ software provides real-time, step-by-step guidance to help even new ultrasound users capture cardiac views and diagnostic-quality images successfully. "We're accelerating the pace of innovation to meet the urgency of today's healthcare challenges. Reaching this milestone is also an important step along our journey of evolving from an imaging company to a healthcare solutions provider, enabling us to deliver holistic and integrated solutions that meet our customers' needs today and will help enable them to stay ahead in a rapidly evolving healthcare environment," said Kass-Hout. GE HealthCare is pushing forward the boundaries of innovation by fostering new ways to use AI, cloud, and software to move the future of healthcare forward in a responsible way in devices, across the care journey, and at the hospital system level. These projects and innovations run the gamut from early R&D to commercially available solutions, often the result of working closely with leading medical institutions, universities, and technology companies to bring in the best thinking from industry, technology, and academia. Regardless of a project's maturity, GE HealthCare combines deep healthcare expertise, a commitment to responsible innovation, and pioneering spirit to help customers address pressing global challenges from aging populations, chronic disease management, remote care, and more. For more information about GE Healthcare's AI-enabled medical device and enterprise software solutions, visit About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. 1 "AI-based Auto Positioning," February 2021, 2 AIR™ Recon DL, 3 Calculated using IB data with an estimation of 20 scans per day, 5.5 days per week, from 4 weeks after delivery to April 2025. 4 Precision DL with Omni Legend 32cm data improves Contrast Recovery (CR) by 11% on average and Contrast-to-Noise Ratio (CNR) by average of 23% as compared to non-ToF reconstruction. CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Using data from Omni Legend 32 cm, CR and CNR were measured using High Precision DL and QCHD. 5 Precision DL with Omni Legend 32cm improves feature quantitation accuracy by 14% as compared to Discovery MI with ToF reconstruction, at comparable noise level. Quantitation accuracy demonstrated using clinical data with inserted lesions of known size, location, and contrast (ground truth). Feature SUVmean from Omni Legend 32 cm with High Precision DL compared to SUVmean from Discovery MI 25 cm with QCFX. View source version on Contacts GE HealthCare Media Contact Sofia Mata-LeclercHead of Communications, Science and

Kerecis to Showcase Fish-Tissue Derived Tendon Protection Surgical Graft at APMA 2025
Kerecis to Showcase Fish-Tissue Derived Tendon Protection Surgical Graft at APMA 2025

Business Wire

timean hour ago

  • Business Wire

Kerecis to Showcase Fish-Tissue Derived Tendon Protection Surgical Graft at APMA 2025

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kerecis, the company pioneering the use of fish-tissue in cellular therapy and tissue regeneration, will debut its latest innovation, SurgiBind® Tendon Protect, at the American Podiatric Medical Association's (APMA) Annual Scientific Meeting in Grapevine, Texas, July 24-27, 2025. The new biologic graft is designed for tendon procedures where no significant tissue loss is present and will be spotlighted during educational and interactive sessions throughout the conference. 'SurgiBind® Tendon Protect was developed in response to a need consistently identified by surgeons. Namely, coverage for repaired tendons that is straightforward to use and compatible with surgical workflows,' said Fertram Sigurjonsson, Founder and CEO of Share APMA 2025 As part of its presence at APMA 2025, Kerecis will exhibit at Booth #805 and host a clinical education event, 'Taste of Iceland,' on Friday, July 25, from 7:00 to 9:00 PM at Mission Plaza, Gaylord Texan Resort. During the session, Dr. James Cottom, DPM, will present 'Gliding into Enhanced Tendon Outcomes with Intact Fish Skin,' a talk exploring the clinical use of SurgiBind® Tendon Protect in tendon repair procedures. Attendees will also have the opportunity to learn more about the broader application of intact fish-tissue grafts while sampling traditional Icelandic cuisine. Designed for Tendon Protection and Surgical Efficiency Each year, an estimated 500,000 tendon procedures are performed in the United States, many of which aim to preserve or restore movement following tendon injury. SurgiBind® Tendon Protect is intended to be wrapped around a repaired tendon during surgery and is cleared for implantation to reinforce soft tissue where weakness exists. The product is a solid, intact fish-tissue based graft, sustainably sourced from North Atlantic cod, and is bioresorbable, non-crosslinked, and designed to be sutured and positioned with ease in the surgical field. 'Tendon Protect was developed in response to a need consistently identified by surgeons. Namely, coverage for repaired tendons that is straightforward to use and compatible with surgical workflows,' said Fertram Sigurjonsson, Founder and CEO of Kerecis. 'The result is a graft that is structurally sound and easy to handle, offering an alternative to mammalian-derived products.' Clinical Use SurgiBind® Tendon Protect is intended for use in ambulatory surgical centers (ASCs) and hospital outpatient departments (HOPDs), providing a physical covering around repaired tendons where there is no significant tissue loss. Its strength and pliability support secure placement and suture fixation and reduces the risk of readmissions or revision procedures related to scarring or adhesion, factors that can increase overall treatment costs and affect reimbursement. Audit-Ready™ To support providers, Kerecis offers coding and reimbursement guidance through its Audit-Ready™ program, designed to align with U.S. payor requirements, reduce administrative burden, and streamline claims and documentation. Available Nationwide SurgiBind® Tendon Protect marks the continued expansion of the Kerecis SurgiBind® portfolio, which now includes options for general surgical, trauma, and tendon-related procedures. The product is currently available across the United States through Kerecis' direct sales force. About Kerecis Kerecis, founded by Fertram Sigurjonsson, develops intact fish tissue derived products for cellular therapy, tissue regeneration, and protection. When grafted onto damaged human tissue or implanted, the patented material supports the body's own processes to heal and regenerate. Because no disease-transfer risk exists between cold-water fish and humans, Kerecis products are only gently processed and retain their similarity to human tissue. The gentle processing preserves the material's original three-dimensional structure, maintaining its inherent natural strength, complexity, and molecules (such as fatty acids). Clinical studies show that Kerecis products heal wounds faster than competitors. Kerecis is the only global manufacturer of medical devices containing intact fish-tissue and is the fastest growing company in the U.S. xenograft biologics skin market. Products include SurgiBind®/SurgiClose®, GraftGuide®, MariGen®, and Shield™ for various medical applications. Committed to the UN Sustainable Development Goals, Kerecis uses sustainably sourced Icelandic fish processed with renewable energy. Kerecis is a part of Coloplast, a leading supplier of intimate healthcare products. For more information about Kerecis and its clinical research, visit Trademarks and registered trademarks are the property of their respective owners.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store